Jubilant Ingrevia Limited (NSE: JUBLINGREA) submitted its financial results for the quarter ended June 30, 2026, to the National Stock Exchange on July 22, 2026, continuing a reporting cycle that has been accompanied by a highly consistent dividend distribution track record stretching back to FY22.

Dividend Structure in FY26

The company's board, at its meeting on May 26, 2026, recommended a Final Dividend of ₹2.50 per equity share for FY26. This followed an Interim Dividend of ₹2.50 per equity share declared on February 4, 2026, bringing the total FY26 dividend payout to ₹5.00 per equity share. The face value of the equity share is ₹1, making the total payout 500% of face value for the year.

Dividend History: A Pattern of Consistency

An analysis of NSE announcements reveals that Jubilant Ingrevia has maintained a remarkably stable dividend policy since its listing. The annual payout in each financial year has been as follows:

The company maintained its dual-tranche payout structure in FY26, mirroring FY22, FY23, and FY25. FY24 was the sole year in the available history where only a final dividend was declared, with no interim tranche, resulting in a halved annual distribution of ₹2.50 per share. The return to ₹5.00 per share in FY25 and its continuation in FY26 signals a restoration of the full payout pattern.

Dividend Yield and Investor Context

With market price data unavailable at the time of publication, a precise dividend yield cannot be calculated. Investors should compute yield as total annual dividend of ₹5.00 divided by the prevailing market price to assess income return. Given that specialty chemical companies in India have historically traded at elevated valuations, yield figures for this segment tend to be in the range of 0.5% to 1.5%, though the actual figure for JUBLINGREA depends on the current traded price.

Company Background

Jubilant Ingrevia Limited is the specialty chemicals and nutrition ingredients arm of the Jubilant Bhartia Group. The company operates across three primary segments: specialty chemicals, nutrition and health solutions, and chemical intermediates. It is a significant manufacturer of pyridine and its derivatives, acetic anhydride, and vitamin B3, supplying to pharmaceutical, agrochemical, and food industries globally. The company was demerged from Jubilant Life Sciences and listed separately on Indian exchanges in 2021.

What the Q1 FY27 Results Filing Signals

The submission of Q1 FY27 results on July 22, 2026, keeps the company within the 60-day regulatory filing window prescribed by SEBI for listed entities. Investors tracking the stock should note that the final dividend of ₹2.50 for FY26 would have an associated record date that determines eligibility. Those who missed the record date for the final dividend should monitor future interim dividend announcements, historically made in the January to February window, based on the company's established calendar. The sustained ₹5.00 annual payout over multiple years underscores a capital return policy that has remained stable even through varied operating cycles in the specialty chemicals sector.